Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Pediatrics
- Sports Medicine
- Women’s Health Care
- Nutrition and Food Science
- Nuclear Medicine
- Transplantation Medicine
- Anesthesiology and Pain Medicine
- Radiology Cases
Abstract
Citation: Ann Clin Case Rep. 2022;7(1):2251.DOI: 10.25107/2474-1655.2251
Vascular Consideration with COVID-19 Vaccination: Clinical Case Report
Haj Abdo M*, Yildirim-Ögüt Z, Housen H, Zistler K, Boulhadid A, Kolletas V, Kadriu E and Seidl K
Department of Cardiology and Intensive Care Unit, The Clinic of Ingolstadt, Germany
*Correspondance to: Mourad Haj Abdo
PDF Full Text Case Report | Open Access
Abstract:
Coronavirus Disease 2019 (COVID-19), the illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to cause significant morbidity and mortality over the World. Globally; numerous vaccines have been developed against COVID-19. In Europe and United states, four vaccines have been approved by the FDA. The Majority of people become Moderna and Pfizer-BioNTech, although certainly side effect may occur, the benefit greatly outweigh the risks. Adverse cardiovascular side effects of the COVID-19 vaccine include myocarditis/pericarditis, Vaccine Induced Thrombotic Thrombocytopenia (VITT) and thromboses, which often related to low platelet levels and VITT in the setting.
Keywords:
Cite the Article:
Haj Abdo M, Yildirim-Ögüt Z, Housen H, Zistler K, Boulhadid A, Kolletas V, et al. Vascular Consideration with COVID-19 Vaccination: Clinical Case Report. Ann Clin Case Rep. 2022; 7: 2251.